Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if XNCR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
33 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 8
208 filers reported a long position in XNCR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $219.8M | 13.7M | +4.7% |
| PRIMECAP MANAGEMENT CO/CA/ | $163.9M | 10.2M | -1.5% |
| BVF INC/IL | $114.9M | 7.1M | Unchanged |
| RTW INVESTMENTS, LP | $109.1M | 6.8M | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. | $84.9M | 5.3M | +7.7% |
| STATE STREET CORP | $79.8M | 5M | +13.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $52.8M | 3.3M | +5.7% |
| TCG Crossover Management, LLC | $39.5M | 2.5M | Unchanged |
| PRICE T ROWE ASSOCIATES INC /MD/ | $37.9M | 2.4M | +51% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $35.7M | 2.2M | -36.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.